FindTrial
Sign In

Combined Thrombus Four-Item Test and Thromboelastography in Diagnosis and Treatment of Patients with Cirrhotic Hemorrhage

Combined Thrombus Four-Item Test and Thromboelastography in Diagnosis and Treatment of Patients with Cirrhotic Hemorrhage

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400090567
Enrollment
Unknown
Registered
2024-10-08
Start date
2024-10-20
Completion date
Unknown
Last updated
2024-10-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with Cirrhotic Hemorrhage

Interventions

Group of liver cirrhosis bleeding:None
Group of patients without bleeding in liver cirrhosis:None

Sponsors

The PLA Rocket Force Characteristic Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Subjects had no communication disorder, normal cognition, and complete clinical data; patients with liver cirrhosis bleeding mainly presented with hematemesis, hematochezia, or positive fecal occult blood test; age = 18 years old.

Exclusion criteria

Exclusion criteria: Patients with psychiatric disorders, incomplete clinical data; patients who died during the treatment period; pregnant or lactating females.

Design outcomes

Primary

MeasureTime frame
TAT;PIC;TM;t-PAIC;R;K;angle; MA;CI;LY30;EPL;—

Countries

China

Contacts

Public ContactRen Zhaoqi

The PLA Rocket Force Characteristic Medical Center

renzq_2024@163.com+86 133 3107 5097

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026